BIO-RAD PRECISION MONITORING
DEAD

Serial Number

90550350

Owner

BIO-RAD LABORATORIES, INC.

Attorney

Margaret C. McHugh

Filing Date

Feb 26, 2021

Add to watchlist:

No watchlists yet
View on USPTO

BIO-RAD PRECISION MONITORING Trademark

Serial Number: 90550350

BIO-RAD PRECISION MONITORING is a trademark filed by BIO-RAD LABORATORIES, INC. on February 26, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

BIO-RAD LABORATORIES, INC. (237 trademarks)

HERCULES, CA 94547

Entity Type: 03

Trademark Details

Filing Date

February 26, 2021

Registration Date

Not Registered

Published for Opposition

March 1, 2022

Goods & Services

Scientific apparatus, instruments and equipment for scientific research, non-medical diagnostic analysis, chemical analysis, clinical analysis and industrial use, namely, DNA and RNA testing apparatus; Scientific laboratory equipment and apparatus, namely, polymerase chain reaction (PCR) apparatus, electrophoresis apparatus, gel electrophoresis apparatus, and thermal cyclers, for use in amplifying, labeling, and analyzing nucleic acids, and parts and consumable parts therefor, namely, tubes, plates, cartridges, holders, and containers for liquids and gels; Laboratory apparatus and instruments, namely, digital Polymerase Chain Reaction (dPCR) instruments for amplifying DNA using digital Polymerase Chain Reaction; Laboratory apparatus and instruments, namely, Polymerase Chain Reaction (PCR) instruments for amplifying DNA using Polymerase Chain Reaction for use in scientific research; Scientific research instruments for use in measuring and quantifying copy number of DNA; Scientific laboratory equipment and apparatus, namely, Polymerase Chain Reaction (PCR) instrument, to perform amplification and analyzation of nucleic acids; Laboratory consumables, namely, plastic adapters; Medical laboratory research instruments for analyzing genes, namely, Real-Time PCR and digital PCR devices; Laboratory apparatus and instruments, namely, digital Polymerase Chain Reaction (dPCR) instruments for amplifying DNA using dPCR; Laboratory apparatus and instruments, namely, Polymerase Chain Reaction (PCR) instruments for amplifying DNA using Polymerase Chain Reaction for use in scientific research; Laboratory apparatus and instruments, namely, Polymerase Chain Reaction (PCR) instruments for amplifying DNA using Polymerase Chain Reaction (PCR) for use in scientific research; Scientific research instruments for use in measuring and quantifying copy number of DNA; Downloadable computer software for use in amplifying, labeling, and analyzing nucleic acids; Computer hardware and downloadable and integrated software for use in gene analysis; Kits comprised of instruments for biochemical, molecular biological and immunological testing, namely, multiplex Polymerase Chain Reaction (PCR) and digital Polymerase Chain Reaction (dPCR) tests, and also comprised of reagents for biochemical, molecular biological and immunological testing, namely, oligonucleotides, antibodies, in-vitro diagnostic preparations, control reagents, electronic or online manuals

Diagnostic preparations for medical purposes; Diagnostic preparations for veterinary purposes; Diagnostic preparations for humans for medical purposes; Diagnostic preparations for medical purposes, namely, reagents, enzymes, oligonucleotides, and buffer solutions for amplifying, labeling, and analyzing biopolymers and nucleic acids for diagnostic medical use and clinical use; Preparations for medical and veterinary purposes, in particular diagnostics, for marking, amplifying, quantification and/or for the analysis of biopolymers, in particular nucleic acids; Chemical, biochemical and biotechnological preparations for medical and veterinary purposes, in particular reagents, enzymes and buffer solutions for marking, amplifying, quantification and/or for the analysis of biopolymers, in particular nucleic acids, in particular reagents, enzymes and buffer solutions for nucleic acid amplification; Chemical reagents for medical or veterinary purposes; Preparations for detecting genetic predispositions for medical purposes; Medical diagnostic reagent kits comprised of clinical medical reagents for clinical use and medical use; Medical diagnostic reagent kits comprised of clinical medical reagents and assays for clinical use and medical use; Diagnostic test kits comprised of medical diagnostic reagents and assays for testing in the field of medical diagnostics; Kits comprising chemicals, reagents, enzymes, and buffer solutions for amplifying and labeling nucleic acids for diagnostic medical use and clinical use; Diagnostic reagents and assays for detecting, diagnosing, treating and monitoring of genetic disorders for medical use; Diagnostic kits consisting primarily of reagents, primers and buffers for detecting, diagnosing, treating and monitoring of genetic disorders for medical use; Chemical test kits for cell assays for medical and veterinary use; Kits comprised primarily of reagents and also containing oligonucleotides, antibodies, in-vitro diagnostic preparations, control reagents, electronic or online manuals and/or instruments for biochemical, molecular biological and immunological testing for medical use; Diagnostic kits consisting primarily of Polymerase Chain Reaction (PCR) mixes for detection of aneuploidies in chromosomes for medical use; Cartridges containing medical diagnostic reagents for use in Polymerase Chain Reaction (PCR) and digital Polymerase Chain Reaction (dPCR); diagnostic preparations for marking, amplifying, quantification and/or for the analysis of biopolymers, in particular nucleic acids for medical and veterinary purposes

Chemical reagents for scientific and medical research purposes; diagnostic reagents for clinical or medical laboratory use; Polymerase Chain Reaction (PCR) and digital Polymerase Chain Reaction (dPCR) reagents for scientific and medical research purposes; reagents for amplification and detection of nucleic acids for scientific and medical research purposes; Assays and reagents for use in genetic research; diagnostic preparations for scientific or research use; diagnostic preparations for clinical or medical laboratory use; kits comprising chemicals, reagents, enzymes, and buffer solutions for amplifying and labeling nucleic acids for scientific and research use; Reagent kits comprising biological protein, DNA primers, polymerase or buffers for scientific and medical research use; Reagent kits comprising biological protein, DNA primers, polymerase or buffers for scientific and medical research use; Chemical, biochemical and biotechnological products for commercial and scientific use, namely, buffer solutions, nucleic acids, nucleic acid derivatives and proteins for chemical analysis; Chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, diagnostic preparations except for human or veterinary medical purposes, non-medical reagents, enzymes, oligonucleotides, and buffer solutions for scientific or research use for amplifying, labeling, and analyzing biopolymers and nucleic acids; Kits comprising chemicals, reagents, enzymes, and buffer solutions for amplifying and labeling nucleic acids for scientific or research use; Kits consisting primarily of reagents and magnetic, polymeric, or gel beads for scientific research use; Kits comprising chemicals for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids or biological or biochemical sample material, in particular chemicals for reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification, sequencing and analysis

Apparatus, namely, DNA and RNA testing apparatus for medical and veterinary diagnostic analysis and determination of medical and veterinary conditions; Medical diagnostic apparatus and instruments, namely, Polymerase Chain Reaction (PCR) instrument, to perform amplification and analyzation of nucleic acids; Medical devices, namely, instruments for use in measuring and quantifying copy number of DNA for medical diagnostic purposes, namely, digital Polymerase Chain Reaction (dPCR) platform; Medical devices, namely, instruments for use in measuring and quantifying copy number of DNA for medical diagnostic purposes, namely, digital Polymerase Chain Reaction (dPCR) platform; Medical devices for detection of infectious disease, namely, digital Polymerase Chain Reaction (dPCR) platform; Diagnostic kits consisting primarily of electronic medical instruments for medical diagnosis and analysis of body fluids, tissues, biomolecules, DNA, antibodies, proteins, molecular material or cellular material

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 15, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 15, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 22, 2024 EXRA
SOU EXTENSION 5 GRANTED
Oct 22, 2024 EX5G
SOU EXTENSION 5 FILED
Oct 22, 2024 EXT5
SOU TEAS EXTENSION RECEIVED
Oct 22, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 19, 2024 EXRA
SOU EXTENSION 4 GRANTED
Apr 18, 2024 EX4G
SOU EXTENSION 4 FILED
Apr 18, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Apr 18, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 11, 2023 EXRA
SOU EXTENSION 3 GRANTED
Oct 9, 2023 EX3G
SOU EXTENSION 3 FILED
Oct 9, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Oct 9, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 22, 2023 EXRA
SOU EXTENSION 2 GRANTED
Jun 21, 2023 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 20, 2023 AITU
NOTICE OF REVIVAL - E-MAILED
May 4, 2023 NREV
SOU EXTENSION RECEIVED WITH TEAS PETITION
May 4, 2023 TPEX
PETITION TO REVIVE-GRANTED
May 4, 2023 PETG
TEAS PETITION TO REVIVE RECEIVED
May 4, 2023 PROA
SOU EXTENSION 2 FILED
Apr 26, 2023 EXT2
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 13, 2022 EXRA
SOU EXTENSION 1 GRANTED
Oct 11, 2022 EX1G
SOU EXTENSION 1 FILED
Oct 11, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 11, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 26, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 1, 2022 NPUB
PUBLISHED FOR OPPOSITION
Mar 1, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 9, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 24, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 21, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 20, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 20, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 21, 2021 GNRN
NON-FINAL ACTION E-MAILED
Jul 21, 2021 GNRT
NON-FINAL ACTION WRITTEN
Jul 21, 2021 CNRT
ASSIGNED TO EXAMINER
Jul 14, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 28, 2021 NWOS
NEW APPLICATION ENTERED
Mar 2, 2021 NWAP